Regulation 19 Amendment of the Medicines for Human Use (Clinical Trials) Regulations 2004
(1)
The Medicines for Human Use (Clinical Trials) Regulations 2004f1 are amended as follows.
(2)
In Schedule 2—
(a)
in paragraph 3 for sub-paragraph (5)(b)(iii)(cc) substitute—
“(cc)an integrated care board.”.
(b)
in paragraph 6, in sub-paragraph (6)(a)(ii) for “the governing body of a clinical commissioning group” substitute “an integrated care board”.
Annotations
Footnotes
- f1
-
S.I. 2004/1031, amended by S.I. 2012/1641; there are other amending instruments but none is relevant.